Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Preventing Postpartum Hemorrhage in High Risk C-Section
NCT03351686Phase 3Completed
- Sponsor
- Mansoura University
- Start
- Aug 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms), sponsored by Mansoura University. Primary endpoint: prevention of postpartum hemorrhage in high risk group. Started Aug 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03351686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03351686.